<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Solvay Sa</title><link href="http://clinicalimmunologyinfo.com/topic/solvay-sa" rel="alternate"></link><id>http://clinicalimmunologyinfo.com/topic/solvay-sa</id><updated>2010-11-02T12:08:53Z</updated><entry><title>Abbott Laboratories Q2 2010 Earnings Call Transcript</title><link href="http://clinicalimmunologyinfo.com/psoriasis/abbott-laboratories-q2-2010-earnings-call-transcript-3489659a" rel="alternate"></link><updated>2010-11-02T12:08:53Z</updated><author><name>SeekingAlpha</name></author><id>tag:clinicalimmunologyinfo.com,2010-11-02:/psoriasis/abbott-laboratories-q2-2010-earnings-call-transcript-3489659a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Autoimmune Disorders"></category><category term="Psoriasis"></category><category term="Clinical Trials"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="India"></category><category term="Medicaid"></category><category term="China"></category><category term="U.S. Securities and Exchange Commission"></category><category term="Royal Bank of Canada"></category><category term="Goldman Sachs Group Inc."></category><category term="Morgan Stanley"></category><category term="Japan"></category><category term="Citigroup Inc."></category><category term="Boston"></category><category term="Europe"></category><category term="Australia"></category><category term="Food and Drug Administration"></category><category term="Brazil"></category><category term="New Zealand"></category><category term="Asia"></category><category term="South America"></category><category term="AstraZeneca Group"></category><category term="Russia"></category><category term="Remicade"></category><category term="Humira"></category><category term="Southeast Asia"></category><category term="New England States"></category><category term="Niaspan"></category><category term="Kaletra"></category><category term="American Society of Clinical Oncology"></category><category term="East Asia"></category><category term="Oceania"></category><category term="South Asia"></category><category term="Wells Fargo &amp; Company"></category><category term="Clinical Immunology"></category><category term="Lupron"></category><category term="David Lewis"></category><category term="Leerink Swann &amp; Co. Inc."></category><category term="Abbott Laboratories Inc."></category><category term="Xience"></category><category term="Solvay SA"></category><category term="Piramal Healthcare Ltd."></category><category term="Larry Biegelsen"></category><category term="Rick Wise"></category><category term="Zydus Cadila Group"></category><category term="Tom Freyman"></category><category term="Matthew Dodds"></category><category term="Neurocrine Biosciences Inc."></category><category term="Cardiovascular Medicine"></category><category term="Skin Health"></category><category term="Jami Rubin"></category><category term="Trilipix"></category><category term="Australian Dollar"></category><category term="Bruce Nudell"></category><category term="Glenn Novarro"></category><category term="Simcor"></category><category term="Generally Accepted Accounting Principles"></category><category term="Mayank Gandhi"></category><category term="Larry Peepo"></category><category term="Creon"></category><category term="Mayank Gandhi Cowen"></category><category term="Derrick Sung Bernstein"></category><category term="HUMIRA International"></category></entry><entry><title>Earnings Preview: Abbott Laboratories</title><link href="http://clinicalimmunologyinfo.com/clinical-immunology/earnings-preview-abbott-laboratories-701771a" rel="alternate"></link><updated>2010-09-01T12:14:40Z</updated><author><name>AP News</name></author><id>tag:clinicalimmunologyinfo.com,2010-09-01:/clinical-immunology/earnings-preview-abbott-laboratories-701771a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Abbott Laboratories Inc." href="/topic/Abbott+Laboratories+Inc." &gt;Abbott Laboratories&lt;/a&gt; reports 3rd-quarter earnings following &lt;a title="Solvay SA" href="/topic/Solvay+SA" &gt;Solvay&lt;/a&gt; acquisition&lt;/div&gt;&lt;div&gt;&lt;p&gt;Drug and medical-device company Abbott Laboratories is scheduled to reports earnings for the third quarter on Wednesday. The following is a summary of key developments and analyst opinion related to the period.&lt;/p&gt;&lt;p&gt;OVERVIEW: Late last month Abbott announced ...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Financial Markets"></category><category term="Market Analysis"></category><category term="Arthritis"></category><category term="Rheumatoid Arthritis"></category><category term="Autoimmune Disorders"></category><category term="Cholesterol"></category><category term="Credit Suisse Group"></category><category term="Europe"></category><category term="Asia"></category><category term="Humira"></category><category term="Eastern Europe"></category><category term="Advanced Medical Optics Inc."></category><category term="Thomson Reuters Corporation"></category><category term="Abbott Laboratories Inc."></category><category term="North Chicago"></category><category term="Catherine Arnold"></category><category term="Solvay SA"></category><category term="Michael Weinstein"></category><category term="Cardiovascular Medicine"></category><category term="Trilipix"></category><category term="JPMorgan Chase &amp; Co."></category><category term="Muscle and Skeletal Health"></category></entry></feed>
